Dopa Decarboxylase < Dopamine < Dopamine Agents

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 232.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000001 (1999)	A E Kingsbury [Royaume-Uni] ; C D Marsden ; O J Foster	The vulnerability of nigral neurons to Parkinson's disease is unrelated to their intrinsic capacity for dopamine synthesis: an in situ hybridization study.
000026 (1999)	E. Marchioni [Italie] ; D. Soragna ; M. Versino ; L. Sibilla ; E. Alfonsi ; A. Romani ; R. Manni ; F. Savoldi	Hemiparkinsonism-hemiatrophy with brain hemihypoplasia.
000045 (1999)	R B Innis [États-Unis] ; K L Marek ; K. Sheff ; S. Zoghbi ; J. Castronuovo ; A. Feigin ; J P Seibyl	Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT.
000081 (1999)	E. Grünblatt [Israël] ; S. Mandel ; T. Berkuzki ; M B Youdim	Apomorphine protects against MPTP-induced neurotoxicity in mice.
000100 (1999)	P J Bédard [Canada] ; P J Blanchet ; D. Lévesque ; J J Soghomonian ; R. Grondin ; M. Morissette ; M. Goulet ; F. Calon ; P. Falardeau ; B. Gomez-Mancilla ; J P Doucet ; G S Robertson ; T. Dipaolo	Pathophysiology of L-dopa-induced dyskinesias.
000107 (1999)	P. Damier [France] ; C. Jaillon ; I. Clavier ; I. Arnulf ; A M Bonnet ; B P Bejjani ; Yves Agid [France]	Dyskinesias assessment in Phase II studies.
000158 (1999)	F. Cardozo-Pelaez [États-Unis] ; S. Song ; A. Parthasarathy ; C. Hazzi ; K. Naidu ; J. Sanchez-Ramos	Oxidative DNA damage in the aging mouse brain.
000159 (1999)	J. Kimber [Royaume-Uni] ; L. Watson ; C J Mathias	Neuroendocrine responses to levodopa in multiple system atrophy (MSA).
000163 (1999)	I. Vermes [Pays-Bas] ; E N Steur ; C. Reutelingsperger ; C. Haanen	Decreased concentration of annexin V in parkinsonian cerebrospinal fluid: speculation on the underlying cause.
000164 (1999)	G. Ebersbach [Autriche] ; M. Stöck ; J. Müller ; G. Wenning ; J. Wissel ; Werner Poewe [Autriche]	Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration.
000268 (2000)	D A Di Monte [États-Unis] ; A. Mccormack ; G. Petzinger ; A M Janson ; M. Quik ; W J Langston	Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.
000279 (2000)	I. Ghorayeb [France] ; P O Fernagut ; I. Aubert ; E. Bezard ; Werner Poewe [Autriche] ; G K Wenning ; F. Tison	Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
000300 (2000)	P R Jarman [Royaume-Uni] ; K P Bhatia ; C. Davie ; S J Heales ; N. Turjanski ; S D Taylor-Robinson ; C D Marsden ; N W Wood	Paroxysmal dystonic choreoathetosis: clinical features and investigation of pathophysiology in a large family.
000324 (2000)	A. Gillies [Royaume-Uni] ; G. Arbuthnott	Computational models of the basal ganglia.
000328 (2000)	M. Rodríguez [Espagne] ; P. Abdala ; J A Obeso	Excitatory responses in the 'direct' striatonigral pathway: effect of nigrostriatal lesion.
000354 (2000)	S. Aime [Italie] ; B. Bergamasco ; M. Casu ; G. Digilio ; M. Fasano ; S. Giraudo ; L. Lopiano	Isolation and 13C-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease.
000390 (2000)	K J Black [États-Unis] ; J W Mink	Response to levodopa challenge in Tourette syndrome.
000397 (2000)	E. Mohr [Canada] ; T. Mendis ; K. Hildebrand ; P P De Deyn	Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: an open pilot trial.
000410 (2000)	N. Murase [Japon] ; R. Kaji ; T. Sakamoto ; H. Shimazu ; S. Matumoto ; N. Kohar ; H. Shibasaki ; J. Kimura	Nicotine-sensitive writer's cramp.
000426 (2001)	A. Korten [Pays-Bas] ; J. Lodder ; F. Vreeling ; A. Boreas ; L. Van Raak ; F. Kessels	Stroke and idiopathic Parkinson's disease: does a shortage of dopamine offer protection against stroke?
000427 (2001)	T H Haapaniemi [Finlande] ; A. Ahonen ; P. Torniainen ; K A Sotaniemi ; V V Myllyl	[123I]beta-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Dopamine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Dopamine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Dopamine
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024